# US 2024/0197632 A1 · Water soluble complex compositions of ibuprofen

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197632 A1
- Document ID: US20240197632A1
- Status: Published application
- Kind: A1
- Application number: 18/425,507
- Filed: 2024-01-29
- Published: 2024-06-20
- Earliest claimed: 2022-12-02
- Assignees: Veterinary Pharmacy Corporation
- Applicants: Veterinary Pharmacy Corporation
- Inventors: Patrick John Smith
- Web page: https://patentgrep.com/patent/US20240197632A1

## CPC

- A61K 9/10: Dispersions; Emulsions
- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A61K 31/192: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid {(cannabinoids A61K31/658)}
- A61K 47/02: Inorganic compounds
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K 47/183: {Amino acids, e.g. glycine, EDTA or aspartame}
- A61K 47/22: Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The disclosure herein describes solubilizing an ibuprofen in water forming a complex with a hydrotrope and controlling the pH of the water or water-based solution. The methods for solubilizing ibuprofen in water are described. These methods can include forming a colloidal suspension of the ibuprofen, and then forming an aqueous colloidal suspension from the colloidal suspension.

## Claims

### Claim 1

A method for solubilizing ibuprofen in water, comprising:
obtaining the ibuprofen;
obtaining the water;
obtaining a hydrotrope; and
forming a colloidal suspension of ibuprofen,
wherein the forming of the colloidal suspension of ibuprofen comprises:
mixing the ibuprofen and the hydrotrope in the water; and
forming an aqueous colloidal suspension of ibuprofen from the colloidal suspension of ibuprofen,
wherein the forming of the aqueous colloidal suspension of ibuprofen comprises:
obtaining a base; and
adding an effective amount of the base to the colloidal suspension of ibuprofen to change a pH of the colloidal suspension of ibuprofen to be greater than 7.

### Claim 2 (depends on 1)

The method of claim 1, wherein the hydrotrope comprises at least one of nicotinamide, niacinamide, caffeine, urea, para amino benzoic acid, tryptophan, proline, phenylalanine, niacin, acetylsalicylic acid, sodium citrate, sodium salicylate, sodium benzoate, or a combination thereof.

### Claim 3 (depends on 1)

The method of claim 1, wherein the hydrotrope comprises an alkali metal salt.

### Claim 4 (depends on 1)

The method of claim 1, wherein the hydrotrope comprises at least one of sodium benzene sulfonate, sodium benzene di-sulfonate, sodium cinnamate, sodium 3-hydroxy-2-naphthoate, sodium para toluene sulfonate, sodium cumene sulfonate, N,N-diethylnicotinamide, N,N-dimethyl benzamide, paraaminobenzoic acid hydrochloride, procaine hydrochloride, sodium alkanoate, urea, N,N-dimethyl urea, resorcinol, pyrogallol, catechol, a,b-napthols,N-diethylnicotinamide (DENA), N,N-dimethylbenzamide (DMBA), sodium xylene sulfonate, ammonium xylene sulfonate, sodium cumene sulfonate, sodium toluene sulfonate, potassium toluene sulfonate, sodium alginate, ibuprofen, arginine, tyrosine, sodium acetate, sodium ascorbate, leucine, valine, glutamine, histidine, asparagine, or a combination thereof.

### Claim 5 (depends on 1)

The method of claim 1, wherein the base comprises at least one of sodium hydroxide, potassium hydroxide, strontium hydroxide, barium hydroxide, rubidium hydroxide, calcium hydroxide, ammonium hydroxide, magnesium hydroxide, lithium hydroxide, cesium hydroxide, DMSO, DMA, Trimethylphosphine, EtOAC, arginine, ammonia, trimethyl ammonia, pyridine, methylamine, alanine, or a combination thereof.

### Claim 6 (depends on 1)

The method of claim 1, wherein the forming of the aqueous colloidal suspension of ibuprofen further comprises:
obtaining a pH buffer; and
adding the pH buffer to the colloidal suspension of ibuprofen.

### Claim 7 (depends on 6)

The method of claim 6, wherein the pH buffer comprises at least one of glycine, arginine, or a combination thereof.

### Claim 8 (depends on 6)

The method of claim 6, wherein the pH buffer comprises at least one of ACES, ADA, ammonium hydroxide, 2-amino-2-methyl-1-propanol, AMPD (2 amino-2-methyl-1,3-propanediol), AMPSO, BES, BICINE, bis-tris, bis-tris propane, borate, boric acid, CABs, Cacodylate, CAPS, CAPSO, Carbonate (Salts included), CHES, Citrate (Salts included), DIPS, EPPS, HEPPS, Ethanolamine, Glycine, glycylglycine, HEPBS, HEPES, HEPPSO, histidine, hydrazine, imidazole, maleate, MES, methylamine, MOBS, MOPS, MOPSO, phosphate (Salts included), piperazine, piperidine, PIPES, POPSO, pyrophosphate, TABS, TAPS, TAPSO, taurine, TES, tricine, triethanolamine, trizma, or a combination thereof.

### Claim 9 (depends on 1)

The method of claim 1, wherein the obtaining the ibuprofen comprises obtaining a tablet comprising the ibuprofen as an active pharmaceutical ingredient (API).

### Claim 10 (depends on 1)

A method for treating illness in an animal, comprising:
forming a medicated water-based colloidal suspension,
wherein the forming the medicated water-based colloidal suspension comprises:
the method of solubilizing ibuprofen in water according to claim 1; and
providing the medicated water-based colloidal suspension to the animal.

### Claim 11

An aqueous colloidal suspension of ibuprofen, comprising:
water;
ibuprofen;
a hydrotrope; and
a base,
wherein the aqueous colloidal suspension of ibuprofen has a pH of greater than 7.

### Claim 12 (depends on 11)

The aqueous colloidal suspension of claim 11, wherein the hydrotrope comprises at least one of nicotinamide, niacinamide, caffeine, urea, para amino benzoic acid, tryptophan, proline, phenylalanine, niacin, acetylsalicylic acid, sodium citrate, sodium salicylate, sodium benzoate, or a combination thereof.

### Claim 13 (depends on 11)

The aqueous colloidal suspension of claim 11, wherein the hydrotrope comprises at least one of sodium benzene sulfonate, sodium benzene di-sulfonate, sodium cinnamate, sodium 3-hydroxy-2-naphthoate, sodium para toluene sulfonate, sodium cumene sulfonate, N,N-diethylnicotinamide, N,N-dimethyl benzamide, paraaminobenzoic acid hydrochloride, procaine hydrochloride, sodium alkanoate, urea, N,N-dimethyl urea, resorcinol, pyrogallol, catechol, a,b-napthols, N-diethylnicotinamide (DENA), N,N-dimethylbenzamide (DMBA), sodium xylene sulfonate, ammonium xylene sulfonate, sodium cumene sulfonate, sodium toluene sulfonate, potassium toluene sulfonate, sodium alginate, ibuprofen, arginine, tyrosine, sodium acetate, sodium ascorbate, leucine, valine, glutamine, histidine, asparagine, or a combination thereof.

### Claim 14 (depends on 11)

The aqueous colloidal suspension of claim 11, wherein the base comprises at least one of sodium hydroxide, potassium hydroxide, strontium hydroxide, barium hydroxide, rubidium hydroxide, calcium hydroxide, ammonium hydroxide, magnesium hydroxide, lithium hydroxide, cesium hydroxide, DMSO, DMA, Trimethylphosphine, EtOAC, arginine, ammonia, trimethyl ammonia, pyridine, methylamine, alanine, or a combination thereof.

### Claim 15 (depends on 11)

The aqueous colloidal suspension of claim 11, further comprising a pH buffer.

### Claim 16 (depends on 15)

The aqueous colloidal suspension of claim 15, wherein the pH buffer comprises at least one of glycine, arginine, or a combination thereof.

### Claim 17 (depends on 15)

The aqueous colloidal suspension of claim 15, wherein the pH buffer comprises at least one of ACES, ADA, ammonium hydroxide, 2-amino-2-methyl-1-propanol, AMPD (2 amino-2-methyl-1,3-propanediol), AMPSO, BES, BICINE, bis-tris, bis-tris propane, borate, boric acid, CABs, Cacodylate, CAPS, CAPSO, Carbonate (Salts included), CHES, Citrate (Salts included), DIPS, EPPS, HEPPS, Ethanolamine, Glycine, glycylglycine, HEPBS, HEPES, HEPPSO, histidine, hydrazine, imidazole, maleate, MES, methylamine, MOBS, MOPS, MOPSO, phosphate (Salts included), piperazine, piperidine, PIPES, POPSO, pyrophosphate, TABS, TAPS, TAPSO, taurine, TES, tricine, triethanolamine, trizma, or a combination thereof.
